Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Saadatzadeh MR
The effective concentration-50% (EC50) of GS 441524 is calculated to be 0
CAN-15-0817
the FDA indicated that indiplon-IR was approvable and plans are to resubmit the application in 2007
Molecular Weight: 167
OSI-930 penem monohydrate Saadatzadeh MROSI 930 is a selective thiophene derived tyrosine kinase inhibitor with potential antineoplastic activity. Tyrosine kinase inhibitor OSI 930 inhibits stem cell factor receptor (c Kit) and the vascular endothelial growth factor receptor 2 (VEGFR2), which may result in the inhibition of both tumor cell proliferation and tumor angiogenesis. Both c Kit and VEGFR2 are overexpressed in a variety of cancers. Check for active clinical trials or closed
US$ 141.00
US$ 162.00
US$ 235.50
US$ 404.50
US$ 154.00
US$ 128.00
US$ 415.00